ArticleSensors (Basel, Switzerland)2026
Surface Functionalization Studies in the Development of Nanohole Plasmonic Sensors.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Localized surface plasmon resonance (LSPR) is an optical phenomenon that occurs when light interacts with free electrons on the surface of metallic thin films, producing intensified electromagnetic fields at specific sites, often called "hot spots". LSPR-based sensing technologies respond to chemical and associated optical interfacial changes. Inherent advantages include enhanced sensitivity, compact size, low production cost, and strong potential for integration into portable, point-of-care diagnostic systems. This study focuses on a detailed investigation into the surface functionalization of localized surface plasmon resonance (LSPR)-based nanohole array (NHA) sensors for biomedical applications. Gold-coated NHA surfaces were functionalized using polyethylene glycol (PEG) self-assembled monolayers (SAMs), enabling specific attachment of biomolecular species. As a proof-of-concept, bovine serum albumin (BSA) and SARS-CoV-2 nanobody proteins were successfully immobilized on the PEGylated surfaces. Individual steps of surface modification including PEGylation, protein immobilization and nanobody immobilization were validated through a dual-method approach which combined measurement of LSPR optical spectral shifts and x-ray photoelectron spectroscopy (XPS) chemical analyses. Reproducibility was assessed across multiple sensors and repeated trials, confirming the repeatability of each functionalization and binding process. The sensor system, consisting of NHA-based plasmonic platform, microfluidics, and a portable optical spectrometer, exhibits the capability for reliable and sensitive, label-free detection of biomolecular targets, including viral antigens, in liquid-phase environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.